Spectrum Pharmaceuticals, Inc. (SPPI) stock has fallen -46.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SPPI stock a score of 35 out of a possible 100. That rank is influenced by a short-term technical score of 4. SPPI's rank also includes a long-term technical score of 5. The fundamental score for SPPI is 96. In addition to the average rating from Wall Street analysts, SPPI stock has a mean target price of $6.75. This means analysts expect the stock to rise 235.82% over the next 12 months.
Should You Sell Spectrum Pharmaceuticals, Inc. (SPPI) Stock Monday?
SPPI has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on SPPI!